Description
This project aims to make the Firm's platform (Ranger Technology) “clinic-compatible” by eliminating user intervention and ensuring the Firm can deliver reagents and instrument throughput at the scale that its customer base demands.
Amendment chain · 5 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $364,734 at start, $475,334 after amendment #5 (+$110,600).
- #02019-06-01$364,734
- #12020-02-28$379,734+$15,000
- #22020-06-04$379,734
- #42021-02-22$365,734-$14,000
- #52021-09-24$475,334+$109,600
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2019-06-01(start date) | $364,734 | — | This project aims to make the Firm's platform (Ranger Technology) “clinic-compatible” by eliminating user inte… |
| #1 amendment | 2020-02-28 | $379,734 | +$15,000 | This project aims to make the Firm's platform (Ranger Technology) “clinic-compatible” by eliminating user inte… |
| #2 amendment | 2020-06-04 | $379,734 | +$0 | This project aims to make the Firm's platform (Ranger Technology) “clinic-compatible” by eliminating user inte… |
| #4 amendment | 2021-02-22 | $365,734 | −$14,000 | This project aims to make the Firm's platform (Ranger Technology) “clinic-compatible” by eliminating user inte… |
| #5 amendment | 2021-09-24 | $475,334 | +$109,600 | This project aims to make the Firm's platform (Ranger Technology) “clinic-compatible” by eliminating user inte… |
Related records · 8
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 821000700)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2020-2021-Q4-967066 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program | $48,772 | FY2021 |
| 172-2020-2021-Q3-960904 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program | $129,834 | FY2021 |
| 172-2020-2021-Q1-951783 | National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program | $91,476 | FY2021 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q1-930016 · retrieved 2026-11-15.